Antimicrobial Therapeutics Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	165 Pages	Coherent Market Insights	June, 2023	CMI18049150

Best Price Guarantee
Price	from $4,500
Length	165 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18049150

Antimicrobial Therapeutics Market, By Drug Class (Antibacterials, Antivirals, Antifungals, Antiparasitics), By Route of Administration (Oral, Topical, Injectable, Others), By Disease Indication (Respiratory Infections, Urinary Tract Infections (UTIs), Skin and Soft Tissue nfections, Sexually Transmitted Infections (STIs), Gastrointestinal Infections, Central Nervous System Infections, Others), By Spectrum of Activity (Broad-spectrum, Narrow-spectrum), By End-user (Hospitals and Clinics, Homecare, Research Institutes), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Antimicrobial therapeutics are medicines that kill or make it harder for bacteria to grow and multiply in people or animals. They are often used to treat serious infections, such as pneumonia or bloodstream infections (BSIs). Antibiotics can be taken by mouth in the form of pills, tablets, or liquids. They can also be injected or given directly into the bloodstream (IV) for more severe infections. They can also be applied to the skin as a cream, spray, or ointment. When used incorrectly, antibiotics can cause serious side effects and lead to resistant microorganisms. This resistance makes it harder to treat infections with the same medicine or even other medicines that are effective against them.

Market Dynamics:

Increased global demand for these antibiotics, particularly in developing countries is expected to propel growth of the global antimicrobial therapeutics market over the forecast period. Moreover, several bacterial infections are resistant to existing medicines. This has led to the development of newer antimicrobial therapeutics, which are expected to drive market growth over the forecast period.

However, growing antimicrobial resistance is a major factor expected to hamper growth of the global antimicrobial therapeutics market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global antimicrobial therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global antimicrobial therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc., Merck & Co., Inc., Novartis AG, Roche Holding AG, AstraZeneca plc., Sanofi SA, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., AbbVie Inc., Allergan plc., and Mylan N.V.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global antimicrobial therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antimicrobial therapeutics market

Detailed Segmentation:

Global Antimicrobial Therapeutics Market, By Drug Class:

Antibacterials

Antivirals

Antifungals

Antiparasitics

Global Antimicrobial Therapeutics Market, By Route of Administration:

Oral

Topical

Injectable

Others

Global Antimicrobial Therapeutics Market, By Disease Indication:

Respiratory Infections

Urinary Tract Infections (UTIs)

Skin and Soft Tissue Infections

Sexually Transmitted Infections (STIs)

Gastrointestinal Infections

Central Nervous System Infections

Others

Global Antimicrobial Therapeutics Market, By Spectrum of Activity:

Broad-spectrum

Narrow-spectrum

Global Antimicrobial Therapeutics Market, By End-user:

Hospitals and Clinics

Homecare

Research Institutes

Global Antimicrobial Therapeutics Market, By Geography:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Company Profile:

Pfizer Inc.

Johnson & Johnson

GlaxoSmithKline plc

Merck & Co., Inc.

Novartis AG

Roche Holding AG

AstraZeneca plc

Sanofi SA

Bayer AG

Bristol Myers Squibb Company

Eli Lilly and Company

Gilead Sciences, Inc.

AbbVie Inc.

Allergan plc

Mylan N.V.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Drug Class; Market Snapshot, By Route of Administration; Market Snapshot, By Disease Indication; Market Snapshot, By Spectrum of Activity; Market Snapshot, By End User; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Increased global demand for these antibiotics; Increasing incidence of infectious diseases; Restraints; Growing antimicrobial resistance; Opportunities; A rise in geriatric population; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Antimicrobial Therapeutics Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Antimicrobial Therapeutics Market , By Drug Class, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023 – 2030; Segment Trends; Antibacterials; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Antivirals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Antifungals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn); Antiparasitics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Antimicrobial Therapeutics Market , By Route of Administration, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023– 2030; Segment Trends; Oral; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Topical; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Injectable; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
7. Antimicrobial Therapeutics Market , By Disease Indication, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023– 2030; Segment Trends; Respiratory Infections; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Urinary Tract Infections (UTIs); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Skin and Soft Tissue Infections; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Sexually Transmitted Infections (STIs); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Gastrointestinal Infections; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Central Nervous System Infections; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Antimicrobial Therapeutics Market , By Spectrum of Activity, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023– 2030; Segment Trends; Broad-spectrum; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Narrow-spectrum; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Antimicrobial Therapeutics Market , By End User, 2023-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2023– 2030; Segment Trends; Hospitals and Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Homecare; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); Research Institutes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion); 10. Antimicrobial Therapeutics Market , By Region, 2023-2030, (US$ Bn); Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2023–2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Spectrum of Activity, 2023-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn); 11. Competitive Landscape; Pfizer Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Johnson & Johnson; GlaxoSmithKline plc.; Merck & Co., Inc.; Novartis AG; Roche Holding AG; AstraZeneca plc.; Sanofi SA; Bayer AG; Bristol Myers Squibb Company; Analyst Views; 12. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on “Antimicrobial Therapeutics Market” - Global forecast to 2030